We demonstrated that, in contrast to classical opioid receptors, ACKR3 won't result in classical G protein signaling and isn't modulated via the classical prescription or analgesic opioids, such as morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists including naloxone. In its place, we founded that LIH383, an ACKR3-selective https://tinai036kic5.anchor-blog.com/profile